Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5386)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qu LS, Zhou GX. Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 5999-6005 [PMID: 24876722 DOI: 10.3748/wjg.v20.i20.5999] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/5999.htm |
| Number | Citing Articles |
| 1 |
Min Kim, James Paik, Pegah Golabi, Thomas Jeffers, Alita Mishra, Zobair M. Younossi. Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States. Journal of Clinical Gastroenterology 2019; 53(8): e341 doi: 10.1097/MCG.0000000000001110
|
| 2 |
M. von Wulffen, P. J. Clark, G. A. Macdonald, A. S. Raj, B. J. Kendall, E. E. Powell, M. P. Jones, G. Holtmann. Liver‐related mortality in countries of the developed world: an ecological study approach to explain the variability. Alimentary Pharmacology & Therapeutics 2016; 44(1): 68 doi: 10.1111/apt.13657
|
| 3 |
Su-Su Zhang, Jin-Xia Liu, Jing Zhu, Ming-Bing Xiao, Cui-Hua Lu, Run-Zhou Ni, Li-Shuai Qu. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis. Japanese Journal of Clinical Oncology 2019; 49(7): 646 doi: 10.1093/jjco/hyz046
|
| 4 |
Guo Wenpei, Li Yuan, Li Liangbo, Mu Jingjun, Wang Bo, Niu Zhiqiang, Ning Yijie, Liu Lixin. Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1142168
|
| 5 |
Patcharin Tepjanta, Kazuhito Fujiyama, Ryo Misaki, Ingorn Kimkong, Benjamin M. Liu. The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion. PLOS ONE 2024; 19(3): e0299403 doi: 10.1371/journal.pone.0299403
|
| 6 |
An Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, Yue Yin, Mengyun Peng, Ding Zheng, Zhaoxuan Peng, Encheng Wang, Xiaodong Wang, Wang Jing. Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis. Heliyon 2024; 10(3): e24437 doi: 10.1016/j.heliyon.2024.e24437
|
| 7 |
Chih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, Chao-Wei Hsu, Wan-Ming Chen, An-Tzu Jao, Cheng-Hung Chien, Ching-Chih Hu, Rong-Nan Chien, Chau-Ting Yeh. Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy. Cancers 2023; 15(13): 3343 doi: 10.3390/cancers15133343
|
| 8 |
Sandra Coenen, Suzanne van Meer, Jan M. Vrolijk, Clemens Richter, Karel J. van Erpecum, Marijke C. Mostert, Irene K. Veldhuijzen, Jurriën G. P. Reijnders, Hanneke van Soest, Kees Dirksen, Joost P. H. Drenth, René P. M. Koene, Maaike Bosschart, Pieter Friederich, Martijn J. ter Borg, Rick H. P. J. Daemen, Joop E. Arends, Marc A. M. T. Verhagen, Christine Schout, B. W. Marcel Spanier. Clinical impact of five large‐scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands. Liver International 2016; 36(10): 1425 doi: 10.1111/liv.13125
|
| 9 |
H. Nina Kim, Craig W. Newcomb, Dena M. Carbonari, Jason A. Roy, Jessie Torgersen, Keri N. Althoff, Mari M. Kitahata, K. Rajender Reddy, Joseph K. Lim, Michael J. Silverberg, Angel M. Mayor, Michael A. Horberg, Edward R. Cachay, Gregory D. Kirk, Jing Sun, Mark Hull, M. John Gill, Timothy R. Sterling, Jay R. Kostman, Marion G. Peters, Richard D. Moore, Marina B. Klein, Vincent Lo Re. Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America. Hepatology 2021; 74(3): 1190 doi: 10.1002/hep.31839
|
| 10 |
Ioannis Varbobitis, George V. Papatheodoridis. The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy. Clinical and Molecular Hepatology 2016; 22(3): 319 doi: 10.3350/cmh.2016.0045
|
| 11 |
Meng Xue, Xiaona Lin, Qiu‐Xiong Lin, Xiaoyong Pu, Jiumin Liu, Xing‐Fang Li, Jun Hou, Xudong Liu, Ren Chen. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk. International Journal of Cancer 2021; 148(12): 2974 doi: 10.1002/ijc.33505
|